Prestige Brands Holdings, Inc. (issuer identified in filing) — FY2016 Form 10-K
Period clarification: The filing covers the fiscal year ended March 31, 2016, not a standalone calendar-year 2015 fourth quarter. The company’s fiscal fourth quarter ended March 31, 2016. The filing is dated May 17, 2016.
Business context
The company markets and distributes over-the-counter healthcare and household-cleaning brands through three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. Growth combines brand investment and product launches with acquisitions. The filing identifies the registrant as Prestige Brands Holdings, Inc.; the supplied company name, Prestige Consumer Healthcare Inc., is not the name shown on this filing.
Financial performance
| Metric | FY2016 | FY2015 |
|---|---|---|
| Total revenue | $806.2 million | $714.6 million |
| Gross profit / margin | $467.2 million / 57.9% | $406.2 million / 56.8% |
| Operating income | $260.3 million | $207.6 million |
| Net income | $99.9 million | $78.3 million |
| Diluted EPS | $1.88 | $1.49 |
| Cash from operating activities | $174.4 million | $156.3 million |
| Capital expenditures | $3.6 million | $6.1 million |
| Cash and cash equivalents at year-end | $27.2 million | $21.3 million |
| Total debt, principal amount | $1,652.5 million | $1,593.6 million |
Revenue rose 12.8%, mainly reflecting acquisitions, particularly Insight and DenTek. North American OTC revenue increased 16.0%; International OTC revenue was essentially flat, and Household Cleaning revenue grew 0.8%. Management reported contribution margin, a non-GAAP segment measure, of $356.4 million, or 44.2% of revenue, versus $306.6 million, or 42.9%, in FY2015.
Operating cash flow increased $18.1 million; management attributed the increase to higher net income and non-cash charges, partly offset by working-capital needs. Investing activities used $223.0 million, including $227.0 million net cash for DenTek. Financing activities provided $54.0 million. Year-end current assets were $249.0 million and current liabilities $106.7 million. The company reported $37.9 million of available borrowing capacity under its ABL revolver.
Material changes and unusual items
- Prestige acquired DenTek on February 5, 2016, for $228.3 million. DenTek contributed $10.7 million of revenue from acquisition through year-end; the filing says its pro forma effect on revenue and earnings was not material.
- FY2016 revenue growth includes $74.1 million from Insight and $9.3 million from DenTek in North American OTC revenue that was not present in the prior-year comparable period.
- The company issued $350 million of 6.375% senior notes due 2024, used proceeds to redeem $250 million of 8.125% notes at a premium and repay the $80 million DenTek bridge loan. Total debt increased by $58.9 million year over year.
- A $18.0 million loss on extinguishment of debt reduced FY2016 pretax income; it principally related to the refinancing and included accelerated debt costs. The fourth quarter recorded $17.5 million of this loss, and Q4 net income was $13.9 million versus $23.8 million in the prior-year quarter.
- General and administrative expense fell to $72.4 million from $81.3 million, mainly because FY2015 included higher Insight acquisition and integration costs. Depreciation and amortization increased to $23.7 million from $17.7 million, reflecting acquired and reclassified intangibles.
- The company changed presentation of debt issuance costs, deducting them from debt and reclassifying prior-year comparative amounts; this was a presentation change, not a change in reported earnings.
Outlook, risks and contingencies
No specific revenue, earnings, or cash-flow guidance is provided in the supplied filing text. Management stated that, excluding acquisitions, operating cash generation and existing credit facilities were expected to support working capital and capital expenditures for the next 12 months, while noting there was no assurance.
Management reported compliance with debt covenants at March 31, 2016, and anticipated compliance during FY2017. Debt agreements restrict additional borrowing, acquisitions, dividends, share repurchases, and other actions; cross-default provisions could accelerate debt. The company had $902.5 million of variable-rate debt; a 1 percentage-point rate increase was estimated to reduce annual pretax earnings and cash flow by approximately $8.8 million.
Key risks include substantial leverage and interest obligations; dependence on Walmart, which represented 20.2% of FY2016 gross revenue; reliance on third-party manufacturers and a primary U.S. distribution center; competition, including private label; regulatory and product-liability exposure; foreign exchange; and acquisition integration. Goodwill and intangible assets totaled $2.68 billion, about 91% of total assets. No impairment was recorded, but Beano, New-Skin, and Debrox had fair values only 9.0%, 8.2%, and 5.1% above carrying values, respectively. The Ecotrin brand’s useful life was reassessed at 20 years and $32.9 million was reclassified to finite-lived intangibles. Routine legal matters were not expected by management to have a material adverse effect; no material specific litigation contingency is identified in the supplied text.
Important facts for investors to verify
- Confirm the intended issuer and period: this is Prestige Brands Holdings, Inc.’s FY ended March 31, 2016 filing, not a standalone “2015 Q4” report.
- Separate acquisition-driven growth from organic performance, especially for Insight, DenTek, and brands with declining sales such as Beano and PediaCare.
- Review debt maturity, interest-rate exposure, covenant headroom, and the limited $37.9 million available ABL capacity against cash of $27.2 million.
- Monitor impairment assumptions and brand performance for Beano, New-Skin, Debrox, and Ecotrin.
- Assess customer concentration, manufacturer continuity, and the impact of product returns, promotions, and input-cost changes on margins and cash conversion.